Need Training?
Build a solid foundation in science, formulation and product development—find out more!
Most Popular in:
Regulatory
New in Regulatory (page 44 of 45)
May 06, 2003 | 02:00 AM CDT
Staking a Claim
By: R. Rasmussen
The bottom line for any company is to make a profit, and one of the most obvious and visible ways to do this is to claim that their product provides everything the consumer wants.
May 06, 2003 | 02:00 AM CDT
Claims Support Literature Review-Part I, Skin Care
By: Charles Fox
This article is the first in a several-part series focusing on claim support. Part 1, published here, centers around aloe barbadensis gel, AHAs, antimicrobials, biopeptides, Coenzyme Q-10, diethylenetriaminepentaacetic acid, evening primrose oil, flavonoi
May 06, 2003 | 02:00 AM CDT
Federal Laboratory Technology
By: Larry Plonsker
The Federal budget for research and development proposed for the fiscal year 2003 is $112 billion. About $59 billion is for defense-related R&D, and about $53 billion is non-defense related.
May 06, 2003 | 02:00 AM CDT
Mexican Cosmetic Regulations: Part 1 of 2
By: David C. Steinberg, Steinberg & Associates
Mexico has a list of products that are regulated as cosmetics. Cosmetics are defined as perfumery and beauty products which, through suitable technical means, can modify the natural odor of the body and maintain and improve its aesthetics.
May 06, 2003 | 02:00 AM CDT
Canadian Environmental Protection Act and Its Personal Care Implications
By: Kathleen Rowland, CCTFA
Canadian Environmental Protection Act and its personal care implications.
May 06, 2003 | 02:00 AM CDT
European Update, Part 3
By: David C. Steinberg, Steinberg & Associates
With the recent approval of the 26th Adaptation of Technical Process (ATP) the Scientific Committee Cosmetics, Non-Food Products (SCCNFP) has already initiated changes for the 27th ATP. At the Feb. 27, 2002, meeting, several imporant decisions were made.
May 06, 2003 | 02:00 AM CDT
Year-End Review of Regulatory Issues
By: David C. Steinberg, Steinberg & Associates
I have been accumulating odds and ends of regulatory issues over the year, and this column-the last of 2002-seems like an ideal place to present them.
May 06, 2003 | 02:00 AM CDT
Claim Support Literature Review-Part IV, Skin Physiology and Properties
By: Charles Fox, Charles Fox Associates
This article is the fourth in a series focusing on claim support. This installment focuses on research in skin physiology in relation to blood circulation, cell turnover, collagen formation, sebum regulation, enzymes, photodamage and wrinkles and line reduction.
May 06, 2003 | 02:00 AM CDT
European Update, Part 2
By: David C. Steinberg, Steinberg & Associates
In a previous column, I reviewed the process of making new amendments to the Cosmetic Directive of the European Union (EU). I briefly mentioned that changes to the eight annexes of the Cosmetic Directive are made by the process referred to as Adaptations to Technical Progress, or ATP.
May 06, 2003 | 02:00 AM CDT
Establishing the Dividing Line: Is Your Product a Drug?
By: Robert J. Buta, Philip G. Trager and Edward J.…
To avoid regulatory penalties, a company developing an OTC product must institute properly administered shelf-life testing programs as an integral part of its product development and marketing efforts.